» Articles » PMID: 34045856

A Retrospective Study of the Effects of Psychotropic Drugs on Neuroendocrine Hormones in Patients with Bipolar Disorder

Overview
Publisher Dove Medical Press
Specialty Psychiatry
Date 2021 May 28
PMID 34045856
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bipolar disorder (BD) is predominantly treated with medication, and previous studies have shown that psychotropic drugs have an effect on the neuroendocrine system. And the objectives of this study were: 1) to assess changes in neuroendocrine hormones of HPA axis and HPT axis in patients with BD after psychotropic drug treatment; 2) to determine differences in the above neuroendocrine hormones between psychotropic drug monotherapy and polytherapy treated patients.

Methods: This study was a retrospective study that included 188 subjects.

Results: After psychotropic drugs treatment, TSH levels increased significantly from baseline (p<0.001) and FT3, TT3, FT4, TT4, ACTH and CORT levels decreased significantly from baseline (p<0.001, p<0.001, p<0.001, p=0.007, p=0.039, p=0.031). There was no significant difference in hormonal changes between the monotherapy group and the polytherapy group, even though the polytherapy group was further divided into 4 subgroups. And there was no correlation between changes in hormones and treatment duration.

Conclusion: Although the incidence of significant HPT axis and HPA axis dysfunction after psychotropic drug treatment is low in patients with BD who have normal baseline neuroendocrine hormone levels, psychotropic drug treatment does suppress HPT axis and HPA axis function irrespective of the use of psychotropic drugs alone or in combination, and duration of psychotropic drug treatment. Therefore, even patients with BD who have normal baseline levels of neuroendocrine hormones should have their neuroendocrine hormone levels regularly monitored after psychotropic drug medication. But, the interval of monitoring can be slightly longer, which can be once every six months after taking psychotropic drugs.

Citing Articles

Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis.

Liu S, Chen X, Li X, Tian L BMC Endocr Disord. 2024; 24(1):248.

PMID: 39551764 PMC: 11572511. DOI: 10.1186/s12902-024-01776-1.


A Rare Case of Myxedema Coma Precipitated by a Single Dose of Haloperidol in a Patient With Paranoid Schizophrenia.

Menendez M, Majekodunmi T, Chohan F, Perez-Castaneda A, Maldonado Rivera H, Angueira-Serrano E Cureus. 2023; 15(9):e45190.

PMID: 37842468 PMC: 10571067. DOI: 10.7759/cureus.45190.


A retrospective study of psychotropic drug treatments in bipolar disorder at acute and maintenance episodes.

Jing P, Su J, Zheng C, Mei X, Zhang X Front Psychiatry. 2023; 14:1057780.

PMID: 36824669 PMC: 9942488. DOI: 10.3389/fpsyt.2023.1057780.

References
1.
Chang K, Keck Jr P, Stanton S, McElroy S, Strakowski S, Geracioti Jr T . Differences in thyroid function between bipolar manic and mixed states. Biol Psychiatry. 1998; 43(10):730-3. DOI: 10.1016/s0006-3223(98)80003-6. View

2.
Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea J, Salamero M . Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 2007; 9(1-2):103-13. DOI: 10.1111/j.1399-5618.2007.00327.x. View

3.
Serafini G, Canepa G, Adavastro G, Nebbia J, Belvederi Murri M, Erbuto D . The Relationship between Childhood Maltreatment and Non-Suicidal Self-Injury: A Systematic Review. Front Psychiatry. 2017; 8:149. PMC: 5609590. DOI: 10.3389/fpsyt.2017.00149. View

4.
Reddy Y, Jhanwar V, Nagpal R, Reddy M, Shah N, Ghorpade S . Prescribing practices of Indian psychiatrists in the treatment of bipolar disorder. Aust N Z J Psychiatry. 2019; 53(5):458-469. DOI: 10.1177/0004867419826718. View

5.
Kelly D, Conley R . Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine. J Clin Psychiatry. 2005; 66(1):80-4. DOI: 10.4088/jcp.v66n0111. View